Blue Owl Capital Holdings »

Cardinal Health shares owned by Blue Owl Capital Holdings

Quarter-by-quarter ownership of Cardinal Health (CAH) shares owned by Blue Owl Capital Holdings from 13F filings

Historical chart of Blue Owl Capital Holdings investment in Cardinal Health

Tip: Access up to 7 years of quarterly data

All positions including Cardinal Health held by Blue Owl Capital Holdings consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cardinal Health by Blue Owl Capital Holdings

Quarter filed Position value Share count Share price at filing
2024-09-30 $190k 1.7k 110.52

More positions owned by Blue Owl Capital Holdings

Nuveen Churchill Direct Lend Com Shs (NCDL)
Klaviyo Com Ser A (KVYO)
Tourmaline Bio (TRML)
Pliant Therapeutics (PLRX)
Cullinan Oncology (CGEM)
Owl Rock Capital Corporation (OBDC)
Larimar Therapeutics (LRMR)
Proshares Tr Ultrapro Qqq (TQQQ)
Engene Holdings (ENGN)
Evercommerce (EVCM)
Acelyrin (SLRN)
Conduent Incorporate (CNDT)
Repare Therapeutics Ord (RPTX)
Context Therapeutics (CNTX)
Ultragenyx Pharmaceutical (RARE)

View all positions for Blue Owl Capital Holdings

Top funds holding Cardinal Health

BlackRock
BlackRock
Vanguard Group
State Street Corporation
Geode Capital Management
Morgan Stanley
Pacer Advisors
Arrowstreet Capital, Limited Partnership
AQR Capital Management
Invesco
Bank of America Corporation
Acadian Asset Management
Northern Trust
Jpmorgan Chase & Co
LSV Asset Management

View all funds holding Cardinal Health